Lack of association of statin use with vitamin D levels in a hospital based population of type 2 diabetes mellitus patients
- PMID: 29643908
- PMCID: PMC5857014
- DOI: 10.12669/pjms.341.11977
Lack of association of statin use with vitamin D levels in a hospital based population of type 2 diabetes mellitus patients
Abstract
Objective: To investigate the relationship of statins (drug given to reduce serum levels of LDL-cholesterol) on vitamin D levels of Pakistani type 2 diabetes mellitus (DM) patients in a hospital in Karachi.
Methods: In a cross-sectional survey, 312 consecutive patients with type 2 DM (219 males and 93 females, age 22-70 years) were recruited with informed consent. A questionnaire was administered to find out whether they were statin users or non-users. Serum was analyzed for concentrations of 25(OH) vitamin D [25(OH)D] and other related biomarkers such as serum cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol, phosphate and calcium using kit methods. Multiple Linear Regression was used to evaluate association of statin use with serum levels of vitamin D while adjusting for related covariates including duration of statin use, duration of type 2 DM and smoking.
Results: Mean concentrations of serum cholesterol, and LDL-cholesterol were lower among statin users compared to statin non-users (P < 0.01), while HDL-cholesterol levels were higher (P<0.01). No relationship was observed between statin use and serum levels of vitamin D (P=0.768), when adjusted for age, gender, BMI, duration of type 2 DM, smoking, serum cholesterol and LDL-cholesterol. The adjusted regression coefficient (β) and standard error [SE(β)] for statin use duration were 0.012 (0.042), when serum levels of vitamin D was taken as an outcome.
Conclusion: Lack of association was found between statin use and vitamin D levels in a hospital-based population of Pakistani patients with type 2 DM.
Keywords: Diabetes mellitus; Pakistani population; Statins; Vitamin D levels.
Conflict of interest statement
Conflict of Interest: The authors declare that there are no conflicts of interest.
References
-
- Ray KK, Kastelein JJ, Boekholdt SM, Nicholls SJ, Khaw KT, Ballantyne CM, et al. The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011. Eur Heart J. 2014;35:960–968. doi:10.1093/eurhearty/ehu107. - PubMed
-
- Zittermann A, Gummert JF, Borgermann JH. The role of vitamin D in dyslipidemia and cardiovascular disease. Curr Pharm Des. 2011;17:933–942. - PubMed
-
- Akhtar S. Vitamin D status of South Asian populations – risks and opportunities. Crit Rev Food Sci Nutr. 2016;56(11):1925–1940. doi:10.1080/10408398.2013.807419. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources